title: Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate.
abstract: The objective of the study was to characterize better the immunologic mechanisms underlying a previously developed animal model of chemical-induced asthma. BALB/c and severe combined immunodeficiency disease (SCID) mice received toluene diisocyanate (TDI) or vehicle on each ear on day 1 and/or day 7. On day 10, they were intranasally challenged with TDI or vehicle. Ventilatory function was monitored by whole body plethysmography for 40 min after challenge. Reactivity to methacholine was measured 23 h later: enhanced pause and actual resistance measurements. Pulmonary inflammation was assessed 1, 6, and 24 h after challenge by bronchoalveolar lavage (BAL). Tumor necrosis factor-alpha and macrophage inflammatory protein (MIP)-2 levels were measured in BAL. Immunological parameters included total IgE, IgG1, and IgG2a in serum, lymphocyte populations in auricular and cervical lymph nodes, and IL-4 and IFN-gamma levels in supernatants of lymph node cells, cultured with or without concanavalin A. Ventilatory changes suggestive of airway obstruction and increased methacholine reactivity were observed in all TDI-sensitized and TDI intranasally instilled mice, except in SCID mice. A neutrophil influx, accompanied by an increase in MIP-2 levels, was found in BAL of all responding groups 6 and 24 h after intranasal challenge. In BALB/c mice an increased level of CD19+ B cells was found in the auricular lymph nodes. IL-4 and IFN-gamma levels were increased in supernatants of concanavalin A-stimulated auricular lymph node cells from BALB/c mice completely treated with TDI. These results indicate that our model is dependent on the presence of lymphocytes, but it is not characterized by a preferential stimulation of Th1 or Th2 lymphocytes.
authors.affiliation: Laboratory of Lung Toxicology, Katholieke Universiteit Leuven, Herestraat 49 bus 706, 3000 Leuven, Belgium.
authors.forename: Maciej
authors.initials: M
authors.lastname: Tarkowski
authors.forename: Jeroen A J
authors.initials: JA
authors.lastname: Vanoirbeek
authors.forename: Hadewijch M
authors.initials: HM
authors.lastname: Vanhooren
authors.forename: Vanessa
authors.initials: V
authors.lastname: De Vooght
authors.forename: Caroline M
authors.initials: CM
authors.lastname: Mercier
authors.forename: Jan
authors.initials: J
authors.lastname: Ceuppens
authors.forename: Benoit
authors.initials: B
authors.lastname: Nemery
authors.forename: Peter H M
authors.initials: PH
authors.lastname: Hoet
mesh_terms: D000403:Airway Resistance / Q000187:drug effects* / Q000276:immunology*; D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000503:physiopathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis; D004195:Disease Models, Animal; D007136:Immunoglobulins / Q000097:blood; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D012867:Skin / Q000187:drug effects* / Q000276:immunology*; D014051:Toluene 2,4-Diisocyanate / Q000008:administration & dosage / Q000276:immunology* / Q000633:toxicity*
chemical_list: D016207:Cytokines; D007136:Immunoglobulins; D016210:Methacholine Chloride; D014051:Toluene 2,4-Diisocyanate